Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Humans around the world dance to the same beat

  • Predicting which glioblastoma patients may benefit from drug treatment

  • When times are tough, parents favor daughters over sons

  • Key element of human language discovered in bird babble

  • How your brain knows it's summer

  • Specialized therapy can aid traumatized children in developing nations

  • Upsetting a fragile alliance triggers a deadly childhood disease

  • Flatworms could replace mammals for some toxicology tests

  • On the brink of chaos: Physicists find phase transition in visual cortex

  • Fundamental differences in how pain is processed in males and females

  •